Pitavastatin shows pomise in overcoming chemotherapy resistance in triple-negative br
Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy.
Linear Mode
